escitalopram has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, R; Chen, X; Lin, Q; Lin, T; Lin, X; Lin, Y; Liu, N; Wu, J; Wu, S; Wu, W; Wu, Y; Xiao, Y; Zeng, G | 1 |
| Berlim, MT; Dos Santos, NR; Richard-Devantoy, S; Turecki, G | 1 |
| Chakrabarty, T; Frey, BN; Kennedy, SH; Lam, RW; McInerney, SJ; Milev, RV; Müller, DJ; Rotzinger, S; Torres, IJ | 1 |
3 trial(s) available for escitalopram and Cognitive Decline
| Article | Year |
|---|---|
Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: A prospective randomized clinical trial.
Topics: Anti-Anxiety Agents; Citrates; Cognition; Cognitive Dysfunction; Escitalopram; Humans; Neuropsychological Tests; Prospective Studies; Serotonin; Serotonin Receptor Agonists; Single-Blind Method; Vascular Depression | 2023 |
The network structure of core depressive symptom-domains in major depressive disorder following antidepressant treatment: a randomized clinical trial.
Topics: Adult; Affect; Antidepressive Agents; Cognitive Dysfunction; Cross-Sectional Studies; Depressive Disorder, Major; Desvenlafaxine Succinate; Escitalopram; Fatigue; Female; Humans; Longitudinal Studies; Male; Normal Distribution; Psychopathology; Suicide | 2021 |
Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
Topics: Adolescent; Adult; Antidepressive Agents; Aripiprazole; Biomarkers; Canada; Cognition; Cognitive Dysfunction; Depressive Disorder, Major; Drug Therapy, Combination; Escitalopram; Female; Humans; Male; Middle Aged; Young Adult | 2021 |